Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-117773
Filing Date
2024-11-13
Accepted
2024-11-13 16:34:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2428266d1_defa14a.htm DEFA14A 12144
2 GRAPHIC tm2428266d1_defa14aimg01.jpg GRAPHIC 4400
  Complete submission text file 0001104659-24-117773.txt   19396
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40363 | Film No.: 241455006
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)